Ultra-safe and cost-effective virucidal technology for single use facemasks
Molecular Plasma Group (MPG), a spin-off from VITO (Belgium) and LIST (Luxembourg) is specialised in grafting organic molecules onto any substrate using their proprietary solvent-free plasma coating technology.
Identified as a fear-factor by hospital management, they learned that pathogens such as SARS-COV-19, landing on the outside of PPE, were a risk factor for self-and cross-contamination. This leads them to develop a virucidal functionality grafted onto the outside of single-use facemasks.
The solution is extremely safe as it uses just a few milligrams of citric acid, a natural food ingredient, and doesn’t influence any of the facemask’s other performance criteria.
MPG succeeded in developing the technology from idea, to commercial production of CE-certified virucidal facemasks, in just 11 months. Production capacity is already up and running in Belgium and Luxembourg. Because of the high benefit at marginal cost, MPG expects that this will become the new global standard in healthcare.
KEY FEATURES
• Robust & scientifically proven technology
• Excellent broad-spectrum virucidal performance
• Extremely safe for the user
• Cost-effective, highly scalable solution
More info: www.molecularplasmagroup.com
Видео Ultra-safe and cost-effective virucidal technology for single use facemasks канала Health House
Identified as a fear-factor by hospital management, they learned that pathogens such as SARS-COV-19, landing on the outside of PPE, were a risk factor for self-and cross-contamination. This leads them to develop a virucidal functionality grafted onto the outside of single-use facemasks.
The solution is extremely safe as it uses just a few milligrams of citric acid, a natural food ingredient, and doesn’t influence any of the facemask’s other performance criteria.
MPG succeeded in developing the technology from idea, to commercial production of CE-certified virucidal facemasks, in just 11 months. Production capacity is already up and running in Belgium and Luxembourg. Because of the high benefit at marginal cost, MPG expects that this will become the new global standard in healthcare.
KEY FEATURES
• Robust & scientifically proven technology
• Excellent broad-spectrum virucidal performance
• Extremely safe for the user
• Cost-effective, highly scalable solution
More info: www.molecularplasmagroup.com
Видео Ultra-safe and cost-effective virucidal technology for single use facemasks канала Health House
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Driven by Health - Mentaal evenwicht bij jongeren - online panelgesprek (15 juni 2021)SPES FORUM - 20 jaar - Een camino van de hoop 04/12/2020Roche Diagnostics Belgium - The Perfect Mix - Health HouseThe Body of the Future - FTI Leuven 2024Breathe better with MoonbirdLaunch DBS Select: The first interactive patient education platform on Deep Brain StimulationRBS - Lazarus Trailer 2021-2022 @Health HouseDiscover Health House!DBS Select (NL)Planet Virus: Preparing for the next pandemic and beyondSeminarie Sociopolis: Bronnen van zorg? - Avond 3 - mevr. Ingrid VerduynSNEEZZ - Allergy Management at your fingertipsDBS Select tour at Health HouseDBS SELECT - Patient testimonial - Veerle - after surgeryZORGI - Hybrid client event at Health HouseSeminarie Sociopolis: Bronnen van zorg? - Avond 4 - mevr Ilse JanssensSeminarie Sociopolis: Bronnen van zorg? - Avond 2 - mevr Mieke VandorpePlanet Virus - Online panelgesprek - The way out of this crisis?Driven by Health: Innovatie en Kanker - een unieke kijk op kankerresearch - 11 oktober 2022Health House goes live: Let's connect in 2022